Overall rank by patents
#23,094
of 50,000 tracked assignees
USPTO PatentsView assignee record - 12 granted patents across 2 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, NLT ranks #23,094 of 50,000 tracked US assignees by granted-patent volume, with 12 patents across 2 technology areas.
USPTO PatentsView assignee plate
Corpus R23094 · Foreign Corporation #23,094 · 12 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Nippon Conlux Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
NLT Spine · this assignee
23 score
3D Lighting Innovati… · lowest
7 score
What this shows NLT's Innovation Score is 22.9/100 (top 89% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
NLT Spine Ltd. is a focused PatentsView assignee: 2 CPC subclasses with 91.7% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2015 (5 grants) versus a trough of 1 in 2018. By volume, NLT sits between Nippon Conlux Co., Ltd. and Noritake Itron Corporation.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NIPPON CONLUX CO., LTD.
12 patents
NIPPON TUNGSTEN CO., LTD.
12 patents
NISHIKAWA Co., Ltd.
12 patents
NISSHINBO BRAKE, INC.
12 patents
NLU PRODUCTS, L.L.C.
12 patents
NOCTRIX HEALTH, INC.
12 patents
NON TYPICAL, INC.
12 patents
NORITAKE ITRON CORPORATION
12 patents
NLT SPINE LTD.
12 patents
What this shows NLT holds 12 patents at rank #23,051, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #23,051 in granted patent volume.
Other assignees with the most granted patents in NLT's primary technology class.
NLT's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 Top 89% higher than 11% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 41.7% |
| 2016 | 3 | 25.0% |
| 2017 | 3 | 25.0% |
| 2018 | 1 | 8.3% |
Top 2 of 2 technology areas
Overall rank by patents
#23,094
of 50,000 tracked assignees
22.9 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.